Recently, a GWAS study in 251 Chinese kidney transplant recipients evaluating more than 773,000 SNPs concluded that CYP3A5*3 genotype accounted for an intervariability in TAC levels of >37% [25]. The gene discussed is CYP3A5; the disease is medical procedure.